Open Access
Systematic Review
Issue
J Oral Med Oral Surg
Volume 28, Number 3, 2022
Article Number 30
Number of page(s) 12
DOI https://doi.org/10.1051/mbcb/2021043
Published online 21 June 2022
  1. Macaulay WL. Lymphomatoid papulosis: a continuing self-healing eruption, clinically benign—histologically malignant. Arch Dermatol 1968;97:23–30. [CrossRef] [PubMed] [Google Scholar]
  2. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768–3785. [CrossRef] [PubMed] [Google Scholar]
  3. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016;127:2375–2390. [CrossRef] [PubMed] [Google Scholar]
  4. Willemze R, Cerroni L, Kempf W. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood 2019;134:1112–1112. [PubMed] [Google Scholar]
  5. Bekkenk MW, Geelen FAMJ, Vader PC van V, Heule F, Geerts M-L, Vloten WA van, et al. Primary and secondary cutaneous CD30+lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 2000;95:3653–3661. [CrossRef] [PubMed] [Google Scholar]
  6. Wieser I, Oh CW, Talpur R, Duvic M. Lymphomatoid papulosis: treatment response and associated lymphomas in a study of 180 patients. J Am Acad Dermatol 2016;74:59–67. [CrossRef] [PubMed] [Google Scholar]
  7. Willemze R, Meyer CJ, Van Vloten WA, Scheffer E. The clinical and histological spectrum of lymphomatoid papulosis. Br J Dermatol 1982;107:131–144. [CrossRef] [PubMed] [Google Scholar]
  8. Allabert C, Estève E, Joly P, Troussard X, Comoz F, Courville P, et al. Atteinte muqueuse dans la papulose lymphomatoïde: quatre cas. Ann Dermatol Venereol 2008;135:273–278. [CrossRef] [PubMed] [Google Scholar]
  9. Chimenti S, Fargnoli MC, Pacifico A, Peris K. Mucosal involvement in a patient with lymphomatoid papulosis. J Am Acad Dermatol 2001;44:339–341. [CrossRef] [PubMed] [Google Scholar]
  10. El Shabrawi-Caelen LE, Kerl H, Cerroni L. Lymphomatoid papulosis: reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C. Arch Dermatol 2004;140:441–447. [PubMed] [Google Scholar]
  11. Saggini A, Gulia A, Argenyi Z, Fink-Puches R, Lissia A, Magaña M, et al. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic t-cell lymphoma. Description of 9 cases. Am J Surg Pathol 2010;34:1168–1175. [CrossRef] [PubMed] [Google Scholar]
  12. Kempf W, Kazakov DV, Schärer L, Rütten A, Mentzel T, Paredes BE, et al. Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas. Am J Surg Pathol 2013;37:1–13. [CrossRef] [PubMed] [Google Scholar]
  13. Karai L, Kadin M, Hsi E, Sluzevich J, Ketterling R, Knudson R, et al. Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis. Am J Surg Pathol 2013;37:1173–1181. [CrossRef] [PubMed] [Google Scholar]
  14. Kempf W, Kazakov DV, Baumgartner H-P. Kutzner H. Follicular lymphomatoid papulosis revisited: a study of 11 cases, with new histopathological findings. J Am Acad Dermatol 2013;68:809–816. [CrossRef] [PubMed] [Google Scholar]
  15. Ross NA, Truong H, Keller MS, Mulholland JK, Lee JB, Sahu J. Follicular lymphomatoid papulosis: an eosinophilic-rich follicular subtype masquerading as folliculitis clinically and histologically. Am J Dermatopathol 2016;38:e1–10. [CrossRef] [PubMed] [Google Scholar]
  16. Crowson AN, Baschinsky DY, Kovatich A, Magro C. Granulomatous eccrinotropic lymphomatoid papulosis. Am J Clin Pathol 2003;119:731–739. [CrossRef] [PubMed] [Google Scholar]
  17. Kempf W, Pfaltz K, Vermeer MH, Cozzio A, Ortiz-Romero PL, Bagot M, et al. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Blood 2011;118:4024–4035. [CrossRef] [PubMed] [Google Scholar]
  18. Melchers RC, Willemze R, Bekkenk MW, de Haas ERM, Horvath B, van Rossum MM, et al. Frequency and prognosis of associated malignancies in 504 patients with lymphomatoid papulosis. J Eur Acad Dermatol Venereol JEADV 2019. [Google Scholar]
  19. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. John Wiley & Sons; 2011. [Google Scholar]
  20. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLOS Med 2009; 6. [Google Scholar]
  21. Lipsey MW, Wilson DB. Practical meta-analysis. Thousand Oaks, CA, US: Sage Publications, Inc; 2001. [Google Scholar]
  22. Littell JH. Evidence-based or biased? The quality of published reviews of evidence-based practices. Child Youth Serv Rev 2008;30:1299–1317. [CrossRef] [Google Scholar]
  23. Kato N, Tomita Y, Yoshida K, Hisai H. Involvement of the tongue by lymphomatoid papulosis. Am J Dermatopathol 1998;20:522–526. [CrossRef] [PubMed] [Google Scholar]
  24. Sciubba J, Said-al-Naief N, Fantasia J. Critical review of lymphomatoid papulosis of the oral cavity with case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:195–204. [CrossRef] [PubMed] [Google Scholar]
  25. Pujol RM, Muret MPG, Bergua P, Bordes R, Alomar A. Oral involvement in lymphomatoid papulosis. Dermatology 2005;210:53–57. [CrossRef] [PubMed] [Google Scholar]
  26. Serra-Guillén C, Requena C, Alfaro A, Hueso L, Sanmartín O, Llombart B, et al. Afectación de la mucosa oral por papulosis linfomatoide. Actas Dermosifiliogr 2007;98:265–267. [CrossRef] [PubMed] [Google Scholar]
  27. Agarwal M, Shenjere P, Blewitt RW, Hall G, Sloan P, Pigadas N, et al. CD30-positive T-cell lymphoproliferative disorder of the oral mucosa − an indolent lesion: report of 4 cases. Int J Surg Pathol 2008;16:286–290. [CrossRef] [PubMed] [Google Scholar]
  28. Fernandez-de-Misa R, García M, Dorta S, Febles C, Hernández-Machín B, Serrano S, et al. Solitary oral ulceration as the first appearance of lymphomatoid papulosis: a diagnostic challenge. Clin Exp Dermatol 2009;35:165–168. [PubMed] [Google Scholar]
  29. Booken N, Heck M, Peitsch KW, Goerdt S, Klembe C-D. Ulcerated nodules on the oral mucosa and fingers: a quiz. Acta Derm Venereol 2013;93:250–254. [CrossRef] [PubMed] [Google Scholar]
  30. Benslama L, Andre CV, Charlotte F, Agbo-Godeau S, Goudot P. Papulose lymphomatoïde de localisation muqueuse: 2 cas. Rev Stomatol Chir Maxillofac Chir Orale 2015;116:111–113. [PubMed] [Google Scholar]
  31. Schwartz Z, Coleman M, Toyohara JP, Freedman PD, Magro CM. Oral lymphomatoid papulosis type C: A diagnostic pitfall, often confused with T-cell lymphoma. Ann Diagn Pathol 2017;31:50–55. [CrossRef] [PubMed] [Google Scholar]
  32. Bretsztajn S, Leturc T, Euvrard E, Bodard A-G. Lymphomatoid papulosis localized to the oral mucosa: case report and literature review. J Oral Med Oral Surg 2019;25:30. [CrossRef] [EDP Sciences] [Google Scholar]
  33. Machan S, Juárez Martín Á, Cullen Aravena D, Haro R, Pielasinski Ú, Fuertes L, et al. Acral lymphomatoid papulosis: report of five cases, differential diagnosis, and review. J Cutan Pathol 2020. [Google Scholar]
  34. Narahara S, Mitate E, Murayama N, Kuwatsuka Y, Murota H, Nagano K, et al. A case of lymphomatoid papulosis arising on the upper lip. J Oral Maxillofac Surg Med Pathol 2021. [Google Scholar]
  35. Cordel N, Tressières B, D’Incan M, Machet L, Grange F, Estève É, et al. Frequency and risk factors for associated lymphomas in patients with lymphomatoid papulosis. Oncologist 2016;21:76–83. [CrossRef] [PubMed] [Google Scholar]
  36. Fernández‐de‐Misa R, Hernández‐Machín B, Servitje O, Valentí‐Medina F, Maroñas‐Jiménez L, Ortiz‐Romero PL, et al. First-line treatment in lymphomatoid papulosis: a retrospective multicentre study. Clin Exp Dermatol 2018;43:137–143. [CrossRef] [PubMed] [Google Scholar]
  37. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088–1101. [CrossRef] [PubMed] [Google Scholar]
  38. Dickersin K. Publication Bias: Recognizing the Problem, Understanding Its Origins and Scope, and Preventing Harm. Publ. Bias Meta-Anal., John Wiley & Sons, Ltd; 2005, p. 9–33. [Google Scholar]
  39. Scherer RW, Langenberg P. Full publication of results initially presented in abstracts. Cochrane Database System Rev 2007. [Google Scholar]
  40. Torgerson CJ. Publication bias: the achilles’ heel of systematic reviews? Br J Educ Stud 2006;54:89–102. [CrossRef] [Google Scholar]
  41. Moura FN, Thomas L, Balme B, Dalle S. Dermoscopy of lymphomatoid papulosis. Arch Dermatol 2009;145:966–967. [CrossRef] [PubMed] [Google Scholar]
  42. Nikolaou V, Papadavid E, Ekonomidi A, Dalamaga M, Marinos L, Stratigos A, et al. Association of clinicopathological characteristics with secondary neoplastic lymphoproliferative disorders in patients with lymphomatoid papulosis. Leuk Lymphoma 2015;56:1303–1307. [CrossRef] [PubMed] [Google Scholar]
  43. de Souza A, el-Azhary RA, Camilleri MJ, Wada DA, Appert DL, Gibson LE. In search of prognostic indicators for lymphomatoid papulosis: a retrospective study of 123 patients. J Am Acad Dermatol 2012;66:928–937. [CrossRef] [PubMed] [Google Scholar]
  44. Kempf W, Levi E, Kamarashev J, Kutzner H, Pfeifer W, Petrogiannis-Haliotis T, et al. Fascin expression in CD30-positive cutaneous lymphoproliferative disorders. J Cutan Pathol 2002;29:295–300. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.